Search Results - lisa+polin

1 Results

Sort By:

SH80 Combinations

BackgroundSH35/SH80 evolved from an effort to improve upon the anti-tumor activity of XK469. XK469 is a compound, currently in Phase 1 clinical trials. The clinical trials include patients with bladder, breast, colorectal, esophageal, head and neck, kidney, liver, lung, mesothelioma, pancreas and sarcoma cancers. Moving a chlorine atom from one position...

Published: 9/15/2025 | Inventor(s): Lisa Polin

Keywords(s): Anti-cancer, Compound

Category(s): Technology Category > Therapeutics, Technology Category > Oncology, Technology Category > Life Science